Inspection Record

PharMEDium Services, LLC — FDA 483 Findings

US FDAInspected 2018-10-24Published 2024-01-17 6 findingsAseptic processing and sterility assuranceLaboratory and QC controlsLabeling and packagingOther quality systemEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

2Laboratory and QC controls

Samples taken of drug products for determination of conformance to written specifications are not representative.

3Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that components, in-process materials and drug products conform to appropriate standards of identity, strength, quality, and purity.

4Labeling and packaging

Packaging and labeling records do not include a specimen of all labels used.

5Other quality system

Input to and output from the computer, related systems of formulas, or records or data are not checked for accuracy.

6Equipment and facility

The calibration of instruments is not done at suitable intervals in accordance with an established written program.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

PharMEDium Services, LLC company profile — full history US FDA documents, 2024 Go to Findings search